SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
16-May-24 7:36 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 15-May-24 | Sale (Planned) | 10,455 | $1.88 | $19,654.40 | (6%) 161.93K to 151.48K | |
18-Apr-24 8:20 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 16-Apr-24 | Grant | 80,560 | -- | -- | 99% 81.37K to 161.93K | |
07-Mar-24 4:05 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 05-Mar-24 | Market Sale | 1,540 | $18.73 | $28,841.00 | (2%) 82.91K to 81.37K | 11% |
28-Feb-24 6:13 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 26-Feb-24 | Grant | 36,667 | -- | -- | 79% 46.24K to 82.91K | |
27-Feb-24 5:59 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 23-Feb-24 | Market Sale | 2,838 | $18.76 | $53,230.70 | (6%) 49.08K to 46.24K | 11% |
17-Aug-23 4:35 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 15-Aug-23 | Private Sale (Planned) | 6,164 | $20.88 | $128,686.00 | (11%) 55.25K to 49.08K | |
19-May-23 4:07 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 17-May-23 | Gift | 500 | -- | -- | (< 1%) 55.75K to 55.25K | |
20-Mar-23 8:25 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 16-Mar-23 | Grant | 18,333 | -- | -- | 49% 37.41K to 55.75K | |
28-Feb-23 4:42 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 24-Feb-23 | Private Sale (Planned) | 3,586 | $34.49 | $123,672.00 | (9%) 41.0K to 37.41K | |
28-Feb-22 5:05 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 22-Feb-22 | Grant | 41,000 | -- | -- | 100% 0 to 41.0K |